Stock research, congress trades and insider data
Built on SEC 13F and Form 4 filings and House trade disclosures, with Alpha Scores, weekly briefings and public portfolios on TipRanks. 15+ years in markets.
Ask AlphaScala
NEWQQQ fell 3.04% to 690.56 for the week, 1.78 percentage points worse than SPY's 1.26% decline. NVDA was the weakest heavyweight in the latest session at 204.64, down 4.22%, with MSFT off 1.55% and AAPL 1.23% lower. Pete Sessions disclosed six technology sales in a periodic transaction report, five of them dated Oct. 2. AlphaScala's Alpha Scores for the six largest constituents, last updated Oct. 28, range from 49 to 60.
Read full briefingS&P 500 slips 1.3% as QQQ sheds 3%; Sessions discloses $1.1M in tech sales
Bitcoin at $78,297; QQQ down 3.04% for the week
Ethereum edges up 1.06% as SPY, QQQ slide over week
Gold edges up 0.66% as equities slide; Tether Fund lifts Gold.com stake
Oil quiet as supply catalysts absent; Nasdaq drops 3.04%
Sterling gains 0.3% as dollar flat; COT shows heavy euro shorts, yen longs
Filings data, updated from the source
| COIN | PRICE | CHG | %CHG |
|---|---|---|---|
| LINK | 10.75 | -0.09 | -0.82 ▼ |
| LTC | 51.65 | -0.53 | -1.02 ▼ |
| XRP | 1.1602 | -0.0038 | -0.33 ▼ |
| DOT | 0.891 | -0.0070 | -0.78 ▼ |
| DOGE | 0.0714 | -0.0003 | -0.39 ▼ |
| AVAX | 8.208 | -0.0250 | -0.30 ▼ |
| ADA | 0.1806 | -0.0012 | -0.66 ▼ |
| BTC | 76,039.81 | +172.22 | +0.23 ▲ |
| ETH | 2,240.79 | +0.55 | +0.02 ▲ |
| SOL | 89.57 | -0.24 | -0.27 ▼ |
| PAIR | BID | CHG | %CHG |
|---|---|---|---|
| EUR/GBP | 0.8344 | +0.0000 | +0.00 ▲ |
| EUR/JPY | 176.57 | +0.00 | +0.00 ▲ |
| GBP/JPY | 211.61 | -0.00 | -0.00 ▼ |
| USD/JPY | 158.48 | +0.00 | +0.00 ▲ |
| USD/CHF | 0.8197 | -0.0001 | -0.01 ▼ |
| TICKER | PRICE | CHG | %CHG |
|---|---|---|---|
| WMT | 125.52 | -2.20 | -1.72 ▼ |
| V | 422.65 | +0.06 | +0.01 ▲ |
| JPM | 334.49 | -2.85 | -0.84 ▼ |
| TSLA | 358.22 | +14.53 | +4.23 ▲ |
| META | 610.15 | +5.07 | +0.84 ▲ |
Latest Analysis
View AllAlphaScala Updates
Top market moves, trading setups, broker insights. Free, no spam.